2020
DOI: 10.1021/acssynbio.9b00433
|View full text |Cite
|
Sign up to set email alerts
|

Unlocking Applications of Cell-Free Biotechnology through Enhanced Shelf Life and Productivity of E. coli Extracts

Abstract: Cell-free protein synthesis (CFPS) is a platform biotechnology that enables a breadth of applications. However, field applications remain limited due to the poor shelf-stability of aqueous cell extracts required for CFPS. Lyophilization of E. coli extracts improves shelf life but remains insufficient for extended storage at room temperature. To address this limitation, we mapped the chemical space of ten low-cost additives with four distinct mechanisms of action in a combinatorial manner to identify formulatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
39
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
2

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(43 citation statements)
references
References 63 publications
2
39
0
Order By: Relevance
“…Transitioning the CFPS platform from a research-focused technology to one that is broadly accessible to high school and university classrooms required extensive simplification, reduced costs, and improved reagent stabilization. Our work to date has taken incremental steps toward these milestones by reducing the number of pipetting steps in CFPS setup (Levine et al, 2019a), creating a less-labor intensive cell extract preparation workflow (Levine et al, 2019b), and identifying a low-cost formulation of additives that enables storage and transport of cell-free extract at room temperature (Gregorio et al, 2020). These advances are part of a concerted effort by the research community to make CFPS accessible to classrooms around the world (Huang et al, 2018;Stark et al, 2018Stark et al, , 2019Collias et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Transitioning the CFPS platform from a research-focused technology to one that is broadly accessible to high school and university classrooms required extensive simplification, reduced costs, and improved reagent stabilization. Our work to date has taken incremental steps toward these milestones by reducing the number of pipetting steps in CFPS setup (Levine et al, 2019a), creating a less-labor intensive cell extract preparation workflow (Levine et al, 2019b), and identifying a low-cost formulation of additives that enables storage and transport of cell-free extract at room temperature (Gregorio et al, 2020). These advances are part of a concerted effort by the research community to make CFPS accessible to classrooms around the world (Huang et al, 2018;Stark et al, 2018Stark et al, , 2019Collias et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…13 Moreover, it is known throughout literature that reproducible lysate production from batch to batch is a crucial task, and much effort has been undertaken to develop protocols that solve this issue. 12,13,35,36 The prepared lysates were supplemented with 1 mM of Chi6 DNA to prevent degradation of the functional, linear PCR fragments used for implementing genetic information into microgels that served as reaction environment for CFPS. 37,38 Experiments indicate that addition of Chi6 is not benecial in every experiment (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…2 The expected effect of increasing activity of the CFPS by increasing the crowding agent was not observed. 18,34,36,38,39 While the cytosol of E. coli cells is a very crowded environment of approx. 300-400 mg mL À1 of macromolecules, 40 the reason for our results may lay in a PEG-induced precipitation of mRNA, for instance.…”
Section: Discussionmentioning
confidence: 99%
“…A body of work dedicated to optimization of extract preparation and reaction conditions has simplified, expedited, and improved the cost and performance of E. coli CFE systems (22,28,29). Optimized E. coli-based CFE reactions: (i) quickly synthesize grams of protein per liter in batch reactions (30)(31)(32), (ii) are scalable from the nL to 100 L scale (33,34), and (iii) can be freeze-dried for months of shelf-stability and distribution to the point of care (6,22,29,(35)(36)(37)(38)(39)(40). Freeze-dried CFE systems are poised to make disruptive impacts in biotechnology, having already been leveraged for point-of-use biosensing (41)(42)(43)(44)(45)(46), therapeutic and vaccine production (37,38,47), and educational kits (22,(48)(49)(50).…”
Section: Main Text Introductionmentioning
confidence: 99%